Cough Syrups Probe: ADCs to identify formulations from distribution channels in Kashmir

Kashmir Age
By
Kashmir Age
News Room
We are a team of journalists, editors, and contributors committed to bringing authentic stories and reliable news from every corner of Jammu and Kashmir with integrity...
- News Room
1 Min Read
A researcher at Protein Sciences moves a vial in a lab, Thursday, March 12, 2020, in Meriden, Conn. The biotech company is currently researching a vaccine for COVID-19. For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover from the new virus. (AP Photo/Jessica Hill)

After the government of India ordered a probe into four cough syrups following an alert issued by the World Health Organization (WHO), deputy drug controller Kashmir has asked all Assistant Drug Controllers (ADCs) for immediate action after identifying the formulations from the distribution channels.

According to a communique, a copy of which lies with the news agency—Kashmir News Observer (KNO), deputy drug controller Kashmir stated that all Assistant Drugs Controllers are requested for immediate necessary action after identifying the formulations from the distribution channels.

The communique stated that any action taken or seizures made may be shared with this office for onward appraisal of higher-ups while stressing that the matter may be treated as most urgent.

Notably, the WHO had issued an alert over four cough and cold syrups made by Maiden Pharmaceuticals in India, warning they could be linked to the deaths of 66 children in the Gambia—(KNO)

Share This Article
News Room
Follow:
We are a team of journalists, editors, and contributors committed to bringing authentic stories and reliable news from every corner of Jammu and Kashmir with integrity and professionalism.